Hepatocellular carcinoma (HCC) is a prototypical inflammation-associated cancer and remains a leading contributor of cancer-related fatalities. The typical progression of the disease follows a trajectory
Hepatocellular carcinoma (HCC) remains a global health challenge, with an estimated incidence of >1 million cases by 2025. In spite of several drugs being available